These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 16735661

  • 1. Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs.
    Sabol KE, Echevarria KL, Lewis JS.
    Ann Pharmacother; 2006 Jun; 40(6):1125-33. PubMed ID: 16735661
    [Abstract] [Full Text] [Related]

  • 2. [Methicillin-resistant Staphylococcus aureus (MRSA) in the community].
    Vonk AG, Vandenbroucke-Grauls CM.
    Ned Tijdschr Geneeskd; 2007 Feb 17; 151(7):401-7. PubMed ID: 17343138
    [Abstract] [Full Text] [Related]

  • 3. Community-acquired methicillin-resistant Staphylococcus aureus infections.
    Maltezou HC, Giamarellou H.
    Int J Antimicrob Agents; 2006 Feb 17; 27(2):87-96. PubMed ID: 16423509
    [Abstract] [Full Text] [Related]

  • 4. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
    Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC.
    J Infect; 2007 May 17; 54(5):427-34. PubMed ID: 17070598
    [Abstract] [Full Text] [Related]

  • 5. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
    Arnold FW, Wojda B.
    J Ky Med Assoc; 2005 May 17; 103(5):206-10. PubMed ID: 15918650
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.
    Marcinak JF, Frank AL.
    Expert Rev Anti Infect Ther; 2006 Feb 17; 4(1):91-100. PubMed ID: 16441212
    [Abstract] [Full Text] [Related]

  • 7. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.
    Le J, Lieberman JM.
    Pharmacotherapy; 2006 Dec 17; 26(12):1758-70. PubMed ID: 17125437
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic options for treating community-acquired MRSA.
    Powell JP, Wenzel RP.
    Expert Rev Anti Infect Ther; 2008 Jun 17; 6(3):299-307. PubMed ID: 18588495
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureus.
    LaPlante KL, Rybak MJ, Amjad M, Kaatz GW.
    Pharmacotherapy; 2007 Jan 17; 27(1):3-10. PubMed ID: 17192156
    [Abstract] [Full Text] [Related]

  • 10. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents.
    Tsuji BT, Rybak MJ, Cheung CM, Amjad M, Kaatz GW.
    Diagn Microbiol Infect Dis; 2007 May 17; 58(1):41-7. PubMed ID: 17300912
    [Abstract] [Full Text] [Related]

  • 11. Community-acquired methicillin-resistant Staphylococcus aureus in Madrid, Spain: transcontinental importation and polyclonal emergence of Panton-Valentine leukocidin-positive isolates.
    Cercenado E, Cuevas O, Marín M, Bouza E, Trincado P, Boquete T, Padilla B, Vindel A.
    Diagn Microbiol Infect Dis; 2008 Jun 17; 61(2):143-9. PubMed ID: 18280081
    [Abstract] [Full Text] [Related]

  • 12. Characterization of community-acquired Staphylococcus aureus infections in children.
    Johnson PN, Rapp RP, Nelson CT, Butler JS, Overman S, Kuhn RJ.
    Ann Pharmacother; 2007 Sep 17; 41(9):1361-7. PubMed ID: 17652124
    [Abstract] [Full Text] [Related]

  • 13. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
    Kaka AS, Rueda AM, Shelburne SA, Hulten K, Hamill RJ, Musher DM.
    J Antimicrob Chemother; 2006 Sep 17; 58(3):680-3. PubMed ID: 16840428
    [Abstract] [Full Text] [Related]

  • 14. Healthy children with invasive community-acquired methicillin-resistant Staphylococcus aureus infections.
    Stankovic C, Mahajan PV.
    Pediatr Emerg Care; 2006 May 17; 22(5):361-3. PubMed ID: 16714967
    [Abstract] [Full Text] [Related]

  • 15. Community-acquired methicillin-resistant Staphylococcus aureus infections in children.
    Kaplan SL.
    Semin Pediatr Infect Dis; 2006 Jul 17; 17(3):113-9. PubMed ID: 16934705
    [Abstract] [Full Text] [Related]

  • 16. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR, Golik MV, Davidson L.
    Am J Ther; 2009 Jul 17; 16(4):333-8. PubMed ID: 19617720
    [Abstract] [Full Text] [Related]

  • 17. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA, Yapar N, Sezak N, Cavuş SA, Kurutepe S, Peksel H, Cakir N, Yüce A.
    Mikrobiyol Bul; 2009 Jan 17; 43(1):37-44. PubMed ID: 19334378
    [Abstract] [Full Text] [Related]

  • 18. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.
    Grim SA, Rapp RP, Martin CA, Evans ME.
    Pharmacotherapy; 2005 Feb 17; 25(2):253-64. PubMed ID: 15767239
    [Abstract] [Full Text] [Related]

  • 19. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
    Shapiro A, Raman S, Johnson M, Piehl M.
    N C Med J; 2009 Feb 17; 70(2):102-7. PubMed ID: 19489364
    [Abstract] [Full Text] [Related]

  • 20. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    Leonard SN, Kaatz GW, Rucker LR, Rybak MJ.
    J Antimicrob Chemother; 2008 Dec 17; 62(6):1305-10. PubMed ID: 18801920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.